Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Clin Microbiol Infect. 2012 Aug;18(8):786-94. doi: 10.1111/j.1469-0691.2011.03757.x. Epub 2012 Jan 27.
Patients with pneumonia treated in the internal medicine department (IMD) are often at risk of healthcare-associated pneumonia (HCAP). The importance of HCAP is controversial. We invited physicians from 72 IMDs to report on all patients with pneumonia hospitalized in their department during 2 weeks (one each in January and June 2010) to compare HCAP with community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). We analysed 1002 episodes of pneumonia: 58.9% were CAP, 30.6% were HCAP and 10.4% were HAP. A comparison between CAP, HCAP and HAP showed that HCAP patients were older (77, 83 and 80.5 years; p < 0.001), had poorer functional status (Barthel 100, 30 and 65; p < 0.001) and had more risk factors for aspiration pneumonia (18, 50 and 34%; p < 0.001). The frequency of testing to establish an aetiological diagnosis was lower among HCAP patients (87, 72 and 79; p < 0.001), as was adherence to the therapeutic recommendations of guidelines (70, 23 and 56%; p < 0.001). In-hospital mortality increased progressively between CAP, HCAP and HAP (8, 19 and 27%; p < 0.001). Streptococcus pneumoniae was the main pathogen in CAP and HCAP. Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) caused 17 and 12.3% of HCAP. In patients with a confirmed aetiological diagnosis, the independent risk factors for pneumonia due do difficult-to-treat microorganisms (Enterobacteriaceae, P. aeruginosa or MRSA) were HCAP, chronic obstructive pulmonary diseases and higher Port Severity Index. Our data confirm the importance of maintaining high awareness of HCAP among patients treated in IMDs, because of the different aetiologies, therapy requirements and prognosis of this population.
内科(IMD)收治的肺炎患者通常存在医源性肺炎(HCAP)的风险。HCAP 的重要性存在争议。我们邀请了 72 个 IMD 的医生报告他们科室在两周内(2010 年 1 月和 6 月各一例)收治的所有肺炎住院患者,以比较 HCAP 与社区获得性肺炎(CAP)和医院获得性肺炎(HAP)。我们分析了 1002 例肺炎病例:58.9%为 CAP,30.6%为 HCAP,10.4%为 HAP。CAP、HCAP 和 HAP 之间的比较显示,HCAP 患者年龄更大(77、83 和 80.5 岁;p<0.001),功能状态更差(巴氏量表 100、30 和 65;p<0.001),吸入性肺炎的风险因素更多(18、50 和 34%;p<0.001)。HCAP 患者进行病因诊断检测的频率较低(87、72 和 79;p<0.001),遵循指南治疗建议的比例也较低(70、23 和 56%;p<0.001)。CAP、HCAP 和 HAP 患者的住院死亡率呈递增趋势(8、19 和 27%;p<0.001)。肺炎链球菌是 CAP 和 HCAP 的主要病原体。铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌(MRSA)分别引起 17%和 12.3%的 HCAP。在有明确病因诊断的患者中,导致治疗困难的微生物(肠杆菌科、铜绿假单胞菌或 MRSA)引起肺炎的独立危险因素为 HCAP、慢性阻塞性肺疾病和较高的波特严重指数。我们的数据证实了 IMD 收治的患者中需要高度重视 HCAP 的重要性,因为该人群的病因、治疗需求和预后不同。